## Current Re-Review Status
- Critical blockers appear resolved:
  - Canon Timeline now explicit and consistent (Year 1=2026, Year 2=2027, Year 3=2028): [VISION_CANON.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/VISION_CANON.md#L121-L138), [ICP_AND_PERSONAS.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/ICP_AND_PERSONAS.md#L315-L334), [MARKET_STRATEGY.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/MARKET_STRATEGY.md#L226-L232)
  - Multi-CRM sequencing aligned to 2028+: [PRD.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/PRD.md#L345-L354), [SYSTEM_ARCHITECTURE.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/SYSTEM_ARCHITECTURE.md#L545-L555)
  - Marketplace scope in Year 1 shifted to curated library wording: [PRD.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/PRD.md#L345-L354), [MARKET_STRATEGY.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/MARKET_STRATEGY.md#L133-L149)
  - README typo no longer present.

## Remaining Canon Issue (Needs One More Pass)
- Audit log retention is still inconsistent between PRD and System Architecture:
  - PRD: audit logs retained 7 years; execution logs 90 days: [PRD.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/PRD.md#L296-L303)
  - System Architecture: audit logs show 90-day retention by default: [SYSTEM_ARCHITECTURE.md](file:///Users/ranjansingh/Desktop/NeuronX/PRODUCT/SYSTEM_ARCHITECTURE.md#L496-L500)

## Plan
### 1) Fix Remaining Audit/Retention Contradiction
- Update `PRODUCT/SYSTEM_ARCHITECTURE.md` audit/compliance bullets to match PRD’s defined split:
  - Audit logs: 7-year retention
  - Execution logs: 90-day retention (configurable)
  - Optional: one-line note on “cryptographic tombstone” for PII deletion alignment.

### 2) Tighten Residual Consistency
- Update `PRODUCT/PRD.md` “Open Questions” parenthetical that still says “Year 2 vs Year 3” for Multi‑CRM to match the now-canonical 2028+ sequencing.

### 3) Optional Credibility Upgrade (Non-Blocking)
- Improve `PRODUCT/MARKET_STRATEGY.md` assumptions table by adding actual citations for TAM/SAM inputs (or clearly labeling as hypotheses if citations aren’t available).

### 4) Produce Re-Review Artifact
- Create a new artifact (leave the original Phase A review intact):
  - `COCKPIT/artifacts/TRAE_REVIEW/REVIEW_PHASE_A_REREVIEW.md`
- Use the same mandated structure from `FRAMEWORK/TRAE_HANDOFF_PROMPT.md`, but focus only on:
  - Confirmed fixes
  - Any remaining required actions
  - Updated verdict (expected to move to APPROVE once the retention contradiction is removed).

### 5) Final Communication
- After artifact creation, respond with exactly: `Trae has finished` (blind protocol).